Pressures behind the rising costs in Canadian private drug plans pre- and post- COVID-19 pandemic : 2018-2023 = Pressions à l'origine de l'augmentation des coûts des régimes privés d'assurance-médicaments...: H82-67/2025-PDF
"Private drug plans play an important role in the Canadian healthcare system, and costs are a major concern for plan sponsors. This study explores the key cost pressures for private drug plans, differentiating between short-term and long-term effects, and highlighting the impact of the COVID-19 pandemic"--Objective.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.965454&sl=0
| Department/Agency |
|
|---|---|
| Title | Pressures behind the rising costs in Canadian private drug plans pre- and post- COVID-19 pandemic : 2018-2023 = Pressions à l'origine de l'augmentation des coûts des régimes privés d'assurance-médicaments au Canada avant et après la pandémie de COVID-19 : 2018-2023 / Yvonne Zhang. |
| Variant title |
|
| Publication type | Monograph |
| Language | Bilingual-[English | French] |
| Format | Digital text |
| Electronic document | |
| Parallel description | [French] |
| Note(s) |
|
| Publishing information |
|
| Author / Contributor |
|
| Description | 1 online resource (1 page) : colour illustrations |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: